Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARROW
2022-003217-11Phase 4Active
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefuroxime and metronidazole in Intra-abdominal infection (IAI) and surgical site infection (SSI) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Occurrence of abdominal infection defined as organ/space infection. Started Feb 2023; status: active.
02
Drugs
cefuroximemetronidazole
03
Conditions
Intra-abdominal infection (IAI)surgical site infection (SSI)
Beyond the preview
Go deeper on 2022-003217-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003217-11.